{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T05:04:56Z","timestamp":1789275896729,"version":"build-2803163510"},"reference-count":38,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"crossref","award":["03LW0048K"],"award-info":[{"award-number":["03LW0048K"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research","doi-asserted-by":"crossref","award":["16LW0450"],"award-info":[{"award-number":["16LW0450"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"award":["03LW0048K"],"award-info":[{"award-number":["03LW0048K"]}],"id":[{"id":"https:\/\/ror.org\/04pz7b180","id-type":"ROR","asserted-by":"publisher"}]},{"award":["16LW0450"],"award-info":[{"award-number":["16LW0450"]}],"id":[{"id":"https:\/\/ror.org\/04pz7b180","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The lymphocytic choriomeningitis virus (LCMV) represents a strong T cell activating virus with anti-tumoral properties. In recent work, we developed an attenuated cancer cell-adapted reassortant LCMV strain carrying tumor-tropic mutations. The immunological mechanisms underlying these mutations remained unknown. Here, we passaged wild-type LCMV-WE in human lung cancer H1975 cells for 52 passages. After 29 passages, the virus acquired the GP1 mutations I181M and R185W, involved in viral receptor interactions, which remained stable throughout the subsequent 33 passages. Compared with wild-type LCMV-WE, LCMV-P52 showed increased infectivity, partly concomitant with enhanced propagation in human tumor cells. In vivo, LCMV-P52 induced reduced type I interferon (IFN-I) responses and showed accelerated expansion in CD169+ macrophages. Propagation within the splenic marginal zone correlated with accelerated priming of virus-specific CD8+ T cells and limited liver tissue damage. Mechanistic in vitro experiments showed that the I181M and R185W mutations were associated with substantially reduced infection of plasmacytoid dendritic cells (pDCs). Collectively, the I181M and R185W mutations limit systemic IFN-I induction and accelerate LCMV propagation in CD169+ macrophages, correlating with improved CD8+ T cell function and reduced liver damage. These findings provide mechanistic insight into how defined GP mutations can modulate viral tropism and antiviral immune responses.<\/jats:p>","DOI":"10.3390\/v18091002","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:51:37Z","timestamp":1789123897000},"page":"1002","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mutations at Positions 181 and 185 Within the LCMV GP Protein Increase Tumor Cell Infectivity, Limit Induction of Type I Interferon, and Accelerate T Cell Activation"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2900-6983","authenticated-orcid":false,"given":"Michael","family":"Bergerhausen","sequence":"first","affiliation":[{"name":"Abalos Therapeutics, 40225 D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5339-6942","authenticated-orcid":false,"given":"Lisa","family":"Holnsteiner","sequence":"additional","affiliation":[{"name":"Institute of Immunology, University Hospital Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Sarah-Kim","family":"Friedrich-Becker","sequence":"additional","affiliation":[{"name":"Abalos Therapeutics, 40225 D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]},{"given":"Zhongwen","family":"Hu","sequence":"additional","affiliation":[{"name":"Institute of Immunology, University Hospital Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3578-7179","authenticated-orcid":false,"given":"Rosa","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Institute of Immunology, University Hospital Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Dethardt","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Abalos Therapeutics, 40225 D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"given":"Marcus","family":"Kostka","sequence":"additional","affiliation":[{"name":"Abalos Therapeutics, 40225 D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]},{"given":"Tim","family":"Brandenburg","sequence":"additional","affiliation":[{"name":"Institute of Immunology, University Hospital Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Haifeng C.","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine II, Medical Faculty, Heinrich Heine University, 40225 D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"}]},{"given":"Cornelia","family":"Hardt","sequence":"additional","affiliation":[{"name":"Institute of Immunology, University Hospital Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]},{"given":"J\u00f6rg","family":"Vollmer","sequence":"additional","affiliation":[{"name":"Abalos Therapeutics, 40225 D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Philipp A.","family":"Lang","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine II, Medical Faculty, Heinrich Heine University, 40225 D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Karl Sebastian","family":"Lang","sequence":"additional","affiliation":[{"name":"Institute of Immunology, University Hospital Essen, 45147 Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.3390\/v4112650","article-title":"Role of lymphocytic choriomeningitis virus (LCMV) in understanding viral immunology: Past, present and future","volume":"4","author":"Zhou","year":"2012","journal-title":"Viruses"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"102411","DOI":"10.1016\/j.xcrm.2025.102411","article-title":"Optimized arenaviruses with tumor-tropic mutations promote safe anti-tumor efficacy via sustainable immune modulatory properties","volume":"6","author":"Lang","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ni.2169","article-title":"Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus","volume":"13","author":"Honke","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Honke, N., Shaabani, N., Zhang, D.E., Iliakis, G., Xu, H.C., Haussinger, D., Recher, M., Lohning, M., Lang, P.A., and Lang, K.S. (2013). Usp18 driven enforced viral replication in dendritic cells contributes to break of immunological tolerance in autoimmune diabetes. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003650"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2015.10.004","article-title":"Two separate mechanisms of enforced viral replication balance innate and adaptive immune activation","volume":"67","author":"Shaabani","year":"2016","journal-title":"J. Autoimmun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.immuni.2012.10.022","article-title":"Chronic but not acute virus infection induces sustained expansion of myeloid suppressor cell numbers that inhibit viral-specific T cell immunity","volume":"38","author":"Norris","year":"2013","journal-title":"Immunity"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/eji.200425730","article-title":"MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection","volume":"35","author":"Zhou","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jneuroim.2007.11.018","article-title":"Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88\/Mal-dependent inflammatory responses","volume":"194","author":"Zhou","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4049\/jimmunol.182.2.1099","article-title":"Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection","volume":"182","author":"Kalinke","year":"2009","journal-title":"J. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.immuni.2005.01.005","article-title":"Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling","volume":"22","author":"Hahm","year":"2005","journal-title":"Immunity"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s42003-021-02028-x","article-title":"Slow viral propagation during initial phase of infection leads to viral persistence in mice","volume":"4","author":"Xu","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Friedrich-Becker, S.K., Bergerhausen, M., Berry, A., Bhat, H., Li, F., Schmitz, R., Holnsteiner, L., M\u00fcller, D., Xu, H., and Lang, P.A. (Viruses, 2026). Lymphocytic Choriomeningitis Virus Bearing GPC Mutations for Enhanced Tumor Tropism and Strong Anti-Tumor Activity, Viruses, in press.","DOI":"10.3390\/v18090998"},{"key":"ref_14","unstructured":"Bergerhausen, M. (2024). The Generation and Characterization of a Beneficial Anti-Tumoral Lymphocytic Choriomeningitis Virus Strain. [MD. Thesis, Institute of Immunology, Universit\u00e4t Duisburg-Essen]."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nsmb.3210","article-title":"Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV","volume":"23","author":"Hastie","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S1097-2765(02)00777-3","article-title":"Template switching by RNA polymerase II in vivo. Evidence and implications from a retroviral system","volume":"10","author":"Kandel","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"12033","DOI":"10.1128\/JVI.77.22.12033-12047.2003","article-title":"Mechanism of RNA recombination in carmo- and tombusviruses: Evidence for template switching by the RNA-dependent RNA polymerase in vitro","volume":"77","author":"Cheng","year":"2003","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e00525-19","DOI":"10.1128\/JVI.00525-19","article-title":"Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B In Cellulo","volume":"93","author":"Schult","year":"2019","journal-title":"J. Virol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Honke, N., Shaabani, N., Teijaro, J.R., Christen, U., Hardt, C., Bezgovsek, J., Lang, P.A., and Lang, K.S. (2017). Presentation of Autoantigen in Peripheral Lymph Nodes Is Sufficient for Priming Autoreactive CD8(+) T Cells. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00113"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Duhan, V., Khairnar, V., Kitanovski, S., Hamdan, T.A., Klein, A.D., Lang, J., Ali, M., Adomati, T., Bhat, H., and Friedrich, S.K. (2020). Integrin Alpha E (CD103) Limits Virus-Induced IFN-I Production in Conventional Dendritic Cells. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.607889"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Beier, J.I., Jokinen, J.D., Holz, G.E., Whang, P.S., Martin, A.M., Warner, N.L., Arteel, G.E., and Lukashevich, I.S. (2015). Novel mechanism of arenavirus-induced liver pathology. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122839"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.4049\/jimmunol.2300637","article-title":"High-Affinity-Mediated Viral Entry Triggers Innate Affinity Escape Resulting in Type I IFN Resistance and Impaired T Cell Immunity","volume":"212","author":"Xu","year":"2024","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/JVI.75.1.448-457.2001","article-title":"Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics","volume":"75","author":"Smelt","year":"2001","journal-title":"J. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/v5010241","article-title":"Arenavirus variations due to host-specific adaptation","volume":"5","author":"Zapata","year":"2013","journal-title":"Viruses"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1073\/pnas.040558797","article-title":"Viral persistence in vivo through selection of neutralizing antibody-escape variants","volume":"97","author":"Ciurea","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1084\/jem.193.3.297","article-title":"Impairment of CD4(+) T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants","volume":"193","author":"Ciurea","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ni911","article-title":"Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections","volume":"4","author":"Hunziker","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","article-title":"Identification of \u03b1-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus","volume":"282","author":"Cao","year":"1998","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.1128\/JVI.76.10.5140-5146.2002","article-title":"New World arenavirus clade C, but not clade A and B viruses, utilizes \u03b1-dystroglycan as its major receptor","volume":"76","author":"Spiropoulou","year":"2002","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"115196","DOI":"10.1016\/j.biopha.2023.115196","article-title":"The role of glycosylation patterns of viral glycoproteins and cell entry receptors in arenavirus infection","volume":"166","author":"Gorzkiewicz","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e2119676119","DOI":"10.1073\/pnas.2119676119","article-title":"CD164 is a host factor for lymphocytic choriomeningitis virus entry","volume":"119","author":"Bakkers","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding Toll-like receptors: Recent insights and perspectives in innate immunity","volume":"57","author":"Kawai","year":"2024","journal-title":"Immunity"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1128\/JVI.00155-10","article-title":"Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus","volume":"84","author":"Zhou","year":"2010","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1128\/JVI.00555-06","article-title":"Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus","volume":"80","author":"Zuniga","year":"2006","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Suprunenko, T., and Hofer, M.J. (2019). Complexities of Type I Interferon Biology: Lessons from LCMV. Viruses, 11.","DOI":"10.3390\/v11020172"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1073\/pnas.1423356112","article-title":"CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells","volume":"112","author":"Bernhard","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nm1780","article-title":"Aggravation of viral hepatitis by platelet-derived serotonin","volume":"14","author":"Lang","year":"2008","journal-title":"Nat. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1128\/JVI.03049-15","article-title":"Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses","volume":"90","author":"Meyer","year":"2016","journal-title":"J. Virol."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/9\/1002\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:16:33Z","timestamp":1789272993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/18\/9\/1002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["v18091002"],"URL":"https:\/\/doi.org\/10.3390\/v18091002","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}